Korecyte Bio is an international biotech startup based between the Netherlands and United Kingdom that was established in 2023. Our mission is to develop next-generation CAR-T cellular immunotherapiesKorecyte Bio is an international biotech startup based between the Netherlands and United Kingdom that was established in 2023. Our mission is to develop next-generation CAR-T cellular immunotherapies

Korecyte Bio nominated at DBT Investment Awards

November 2025, Korecyte Bio was recognized as a runner-up for “Most Innovative Company” at the 15th Department for Business and Trade (DBT) Investment Awards, which was hosted by the British Embassy in Amsterdam.

This website uses cookies to ensure that you have the best experience. If you continue to use this site we will assume that you agree to this.